#41 - Dr. Matthew Schwartz, MD and Dr. Thomas Dayspring, MD, FACP, FNLA on Cancer Innovation, Cardiovascular Disease Prevention, and What Everyone Needs to Know (recorded 09/15/25)

Health is wealth, and as advisors the impact we make extends beyond portfolios. In this two-part episode, Jimmy Lee first sits down with his good friend Dr. Matthew Schwartz, radiation oncologist and UNLV faculty member, to explore how proteomics is changing cancer treatment. Then Dr. Thomas Dayspring, one of the world’s foremost educators on lipids and mentor to Dr. Peter Attia, explains why cardiovascular disease remains the number one preventable cause of death, plus the simple blood tests and treatments that can save lives.Disclaimer: This episode is for informational purposes only and does not constitute medical advice. Please consult your physician for personal medical guidance. What you’ll learn:How proteomics differs from genomics and why it could be a game changer for cancer careWhy many oncologists are not yet using this testing and what patients and families should knowThe role of precision oncology in identifying the right treatment at the right timeWhy cardiovascular disease is still the leading killer, and how ApoB and Lp(a) testing can change outcomesTreatment options that go far beyond good vs. bad cholesterol, and what longevity-focused medicine recommendsPractical steps advisors and their clients can take to advocate for their healthChapters00:00 – Welcome and episode purpose02:18 – Dr. Matthew Schwartz on proteomics vs. genomics07:06 – How Ignite testing works and why it matters11:07 – Effectiveness, adoption, and access for patients16:31 – Awareness, advocacy, and making cancer a chronic disease21:23 – Dr. Thomas Dayspring on cardiovascular disease prevention28:36 – ApoB and why particle number drives risk40:12 – Lipoprotein(a), genetics, and early testing52:08 – Treatment options: lifestyle, statins, PCSK9s58:40 – Lowering ApoB, plaque, and longevity goals01:19:21 – Target numbers and why very low is safe01:26:23 – New therapies for Lp(a) and what’s ahead01:33:20 – Diet, imaging, and practical takeaways01:37:56 – Education gap and being your own advocate01:42:39 – Closing thoughts and advisor roleGuests:Dr. Matthew Schwartz, MD, Radiation Oncologist, Comprehensive Cancer Centers of NevadaDr. Thomas Dayspring, MD, FACP, FNLA, Educator on Lipids, Early MedicalHost: Jimmy Lee, CEO, The Wealth Consulting GroupFollow usLinkedIn: https://www.linkedin.com/company/the-wealth-consulting-group/X (Twitter): @WealthCGYouTube: @thewealthconsultinggroupMaking Life Better at The Wealth Consulting GroupIf you are ready to see how WCG helps advisors grow, subscribe for insights, updates, and resources built to make your practice and your life better.Subscribe at bit.ly/wealthcg